Sulfoximine-substituted pyrimidines for use as CDK and/or VEGF inhibitors, the production thereof and their use as drugs

Details for Australian Patent Application No. 2004281960 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Lucking, Ulrich; Jautelat, Rolf; Siemeister, Gerhard; Kruger, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2004281960

PCT Pub. Number WO2005/037800

Priority 103 49 423.5 16.10.03 DE

Filing date 12 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 1 July 2010

International Classifications

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/037800 Priority application(s): WO2005/037800

1 July 2010 Application Accepted

  Published as AU-B-2004281960

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281985-Method for preparing para-phenyl alkynyl benzaldehydes

2004281959-Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases